12 min listen
Neerja Bhatla on a new quadrivalent HPV vaccine
Neerja Bhatla on a new quadrivalent HPV vaccine
ratings:
Length:
12 minutes
Released:
Nov 29, 2023
Format:
Podcast episode
Description
Professor Neerja Bhatla (All India Institute of Medical Sciences, New Delhi, India) discusses her Article on the Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India.Read the full article:https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00480-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanoncContinue this conversation on social!Follow us today at...https://twitter.com/thelancet & https://Twitter.com/TheLancetOncolhttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Released:
Nov 29, 2023
Format:
Podcast episode
Titles in the series (100)
The Lancet Oncology: August 11, 2008 by The Lancet Oncology in conversation with